<DOC>
	<DOCNO>NCT00897143</DOCNO>
	<brief_summary>RATIONALE : Studying sample pleural fluid laboratory patient lung cancer may help doctor identify early lung cancer cell . It may also help study lung cancer future . PURPOSE : This laboratory study look malignant pleural effusion sample patient primary lung cancer see early lung cancer cell identify .</brief_summary>
	<brief_title>Identifying Early Lung Cancer Cells Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Isolate identify lung cancer precursor cell discard pleural fluid specimen obtain routine thoracentesis procedure diagnosis treatment malignant pleural effusion . OUTLINE : Malignant pleural effusion specimen obtain Pathology Department University Hospitals Cleveland analyze use immunomagnetic bead enrichment assay isolate cell epithelial origin . The isolated cell stain fluorescent DNA binding dye , Hoechst 33342 , marker ( i.e. , CD133 , CD24/CD44 ) sort flow cytometry progenitor nonprogenitor subpopulation . The sorted subpopulation separate examine functionally vitro vivo study . Sphere culture study also perform sorted subpopulation . The specimen may also utilized transcriptional profiling study , RNAi study , establishment long-term culture cell line . DNA also isolate stored tumor nonepithelial normal cell compartment future genetic study know unidentified genetic abnormality contribute development lung cancer , EGFR , ErbB2 , K-ras , p53 mutational status .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Cytologically positive malignant pleural effusion secondary primary small cell nonsmall cell lung cancer Recruited Division Hematology/Oncology , Multidisciplinary Thoracic Oncology Group Ireland Cancer Center , inpatient outpatient unit Case Medical CenterUniversity Hospitals PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>non-small cell lung cancer</keyword>
	<keyword>malignant pleural effusion</keyword>
	<keyword>small cell lung cancer</keyword>
</DOC>